Sponsored Symposia

SUNDAY JUNE 11

1200-1330

Concurrent Lunch Symposia

 

 

MONDAY JUNE 12

1200-1330

Concurrent Lunch Symposia

Back to top

Back to top

 

Focusing the Canadian lens: Addressing the complexity of EGFR-T790M in NSCLC and PD-L1 biomarker testing
Sunday June 11, 1200-1330

 

Presented by

Astra Zeneca

 

Click here to RSVP

 

Interactive Sessions:

New paradigms in the molecular pathology of NSCLC and the impact on clinical value for patients

Mahmoud Abdelsalam, Head and Chair of Hematology / Oncology Division, Director of Oncology Clinical Trial, The Moncton Hospital, Moncton, NB

 

Future approaches to address the complexity of EGFR-T790M testing for patients with advanced NSCLC

Alan Spatz, Director of Pathology, Jewish General Hospital, Montreal, QC

 

PD-L1 testing in NSCLC and beyond: A comparison of PD-L1 assays

Michelle Downes, Director of Research, Department of Anatomic Pathology, Sunnybrook Health Science Centre, Toronto, ON

 

Panel discussion and Q&A: Evolution of EGFR-T790M and PD-L1 testing; where do we go from here?

Faculty and audience

 

Click here for more information

 

Back to top

 

Perspective: Differentiating True ET from Prefibrotic MF in Your Practice
Sunday June 11, 1200-1330

 

Presented by

Novartis

 

Speakers:

Sylvain Mailhot, Hemato-pathologist, PathAssistant Laboratory, Atlantic Cancer Research Institute, Moncton, New Brunswick

Catherine Ross, Hemato-pathologist, Juravinski Hospital, Hamilton, Ontario

 

Click here to RSVP

 

Click here for more information

Back to top

 

 

When is NAFLD not NAFLD?
Monday June 12, 1200-1330

 

Presented by

Alexion

 

Speakers:

Subrata Chakrabarti, Chair, Department of Pathology and Laboratory Medicine, Western University; Chief of Pathology and Laboratory Medicine, Gastrointestinal and Liver Pathologist and Clinician Scientist, London Health Sciences Centre & St. Joseph’s Health Centre, London, Ontario

 

Dhanpat Jain, Professor of Pathology and Medicine (Section of Digestive Diseases), Director of Program in Gastrointestinal and Liver Pathology, Yale University School of Medicine, New Haven, Connecticut

 

Click here to RSVP

 

Click here for more information

 

Back to top

 

 

How PD-L1 Testing can Help Pathologists in Improving Cancer Treatment Outcomes with Immunotherapy
Monday June 12, 1200-1330

 

Presented by

Merck

 

Speakers:

Jean-Claude Cutz, Pathologist, St. Joseph’s Healthcare, HRLMP, Dept. of Pathology and Molecular Medicine, McMaster University

 

Stephanie Snow, Medical Oncologist, QEII Health Sciences Centre, Associate Professor, Division of Medical Oncology, Dalhousie University

 

Click here to RSVP

 

Click here for more information

Back to top